What Happened?
Boston, MA-based Ratio Therapeutics Appointed Jacob Hesterman as Chief Data Officer
About the Company
A discovery through early clinical phase pharmaceutical company, Ratio Therapeutics employs a suite of innovative technologies to develop best-in-class targeted radiotherapeutics for the treatment of cancer. Ratio Therapeutics` Trillium™ targeting scaffold combines pharmacokinetic modulation with best-in-class chelation technology to create proprietary small molecule targeting agents to attack a broad array of cancer targets. Our compounds accommodate imaging and therapeutic radioisotopes, ie "theranostics". The tunable nature of our platform combined with small-scale imaging trials in patients results in accelerated, de-risked compound selection.
About the Person
Jacob Hesterman is Chief Data Officer at Ratio Therapeutics. Previously, Jacob held various senior IT leadership roles in the industry.
Info Source
News
Short Profile